Physician profile
Juan I Lombeida
NPI 1043434202
$3,116.24
in general payments reported to CMS, 2019-2025
55 companies · $521 in 2025
The $521 reported for 2025 was more than what 92% of Hospice and Palliative Medicine (Internal Medicine) providers received nationally (typical 2025 total: $77.77).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $486 · 2021: $402 · 2022: $327 · 2023: $307 · 2024: $552 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,380.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $274.57 | 2019-2025 | Libtayo |
| Genzyme Corporation | $254.86 | 2019-2025 | |
| Daiichi Sankyo INC. | $218.91 | 2021-2025 | Enhertu, Datroway |
| Eisai INC. | $176.46 | 2019-2024 | |
| Janssen Biotech, INC. | $173.93 | 2020-2025 | Rybrevant |
| Merck Sharp & Dohme LLC | $150.34 | 2020-2025 | Keytruda, Welireg |
| Bayer Healthcare Pharmaceuticals INC. | $142.05 | 2019-2024 | |
| Astrazeneca Pharmaceuticals Lp | $113.79 | 2020-2024 | Enhertu |
| Takeda Pharmaceuticals U.S.A., INC. | $112.64 | 2019-2025 | Fruzaqla, Hyqvia, Vonvendi |
| Novartis Pharmaceuticals Corporation | $109.06 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $92.07 | 2020-2025 | |
| Ipsen Biopharmaceuticals, INC | $81.27 | 2020-2023 | Somatuline Depot, Onivyde |
| Iovance Biotherapeutics, INC. | $75.70 | 2024-2025 | Amtagvi |
| Kyowa Kirin, INC. | $62.19 | 2019-2021 | |
| Seagen INC. | $53.89 | 2019-2023 | Adcetris, Tukysa |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Lombeida listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.